Literature DB >> 23628411

Proteomic analysis reveals differentially expressed proteins in macrophages infected with Leishmania amazonensis or Leishmania major.

J P B Menezes1, T F Almeida, A L O A Petersen, C E S Guedes, M S V Mota, J G B Lima, L C Palma, G A Buck, M A Krieger, C M Probst, P S T Veras.   

Abstract

CBA macrophages effectively control Leishmania major infection, yet are permissive to Leishmania amazonensis. Employing a transcriptomic approach, we previously showed the up-regulation of the genes involved in the classical pathway of macrophage activation in resistant mice. However, microarray analyses do not evaluate changes in gene expression that occur after translation. To circumvent this analytical limitation, we employed a proteomics approach to increase our understanding of the modulations that occur during infection and identify novel targets for the control of Leishmania infection. To identify proteins whose expression changes in CBA macrophages infected with L. major or L. amazonensis, protein extracts were obtained and digested and the peptides were characterized using multi-dimensional liquid chromatography coupled with tandem mass spectrometry analyses. A total of 162 proteins were selected as potentially modulated. Using biological network analyses, these proteins were classified as primarily involved in cellular metabolism and grouped into cellular development biological networks. This study is the first to use a proteomics approach to describe the protein modulations involved in cellular metabolism during the initial events of Leishmania-macrophage interaction. Based on these findings, we hypothesize that these differentially expressed proteins likely play a pivotal role in determining the course of infection.
Copyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Leishmania amazonensis; Leishmania major; Macrophages; Proteomics

Mesh:

Substances:

Year:  2013        PMID: 23628411     DOI: 10.1016/j.micinf.2013.04.005

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  14 in total

1.  Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters.

Authors:  Sajad Rashidi; Kurosh Kalantar; Gholamreza Hatam
Journal:  J Parasit Dis       Date:  2018-03-05

2.  Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.

Authors:  Alok Kumar Singh; Rajeev Kumar Pandey; Jair Lage Siqueira-Neto; Yong-Jun Kwon; Lucio H Freitas-Junior; Chandrima Shaha; Rentala Madhubala
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

3.  Expression Profile of Genes Related to the Th17 Pathway in Macrophages Infected by Leishmania major and Leishmania amazonensis: The Use of Gene Regulatory Networks in Modeling This Pathway.

Authors:  Leilane Oliveira Gonçalves; Andrés F Vallejo Pulido; Fernando Augusto Siqueira Mathias; Alexandre Estevão Silvério Enes; Maria Gabriela Reis Carvalho; Daniela de Melo Resende; Marta E Polak; Jeronimo C Ruiz
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 4.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 5.  The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery.

Authors:  Suzanne Lamotte; Gerald F Späth; Najma Rachidi; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2017-06-08

6.  Proteome profiling of human cutaneous leishmaniasis lesion.

Authors:  Claire da Silva Santos; Sanaz Attarha; Ravi Kanth Saini; Viviane Boaventura; Jackson Costa; Ricardo Khouri; Manoel Barral-Netto; Cláudia Ida Brodskyn; Serhiy Souchelnytskyi
Journal:  J Invest Dermatol       Date:  2014-09-10       Impact factor: 8.551

Review 7.  Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection.

Authors:  Patrícia Sampaio Tavares Veras; Juliana Perrone Bezerra de Menezes
Journal:  Int J Mol Sci       Date:  2016-08-19       Impact factor: 5.923

8.  In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.

Authors:  Carlos Eduardo Sampaio Guedes; Beatriz Rocha Simões Dias; Antonio Luis de Oliveira Almeida Petersen; Kercia Pinheiro Cruz; Niara de Jesus Almeida; Daniela Rodrigues Andrade; Juliana Perrone Bezerra de Menezes; Valéria de Matos Borges; Patricia Sampaio Tavares Veras
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-05       Impact factor: 2.743

Review 9.  In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of Leishmania-Infected Macrophages.

Authors:  Patricia Sampaio Tavares Veras; Pablo Ivan Pereira Ramos; Juliana Perrone Bezerra de Menezes
Journal:  Front Cell Infect Microbiol       Date:  2018-09-19       Impact factor: 5.293

Review 10.  Application of Dendrimers for the Treatment of Infectious Diseases.

Authors:  Zandile Mhlwatika; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2018-08-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.